Rachel Zayas

Co-Founder & CEO

Zayas has a Masters in Biotechnology and Business, previously launched a biotech venture and worked at MIT in cancer research developing gene silencing therapeutics using the RNA interference pathway. Zayas is currently a fellow for Healthworx (the investment arm of CareFirst BlueCross BlueShield), she has presented work at AASLD (liver disease conference) and published work in Hepatology. Zayas has written two fiction novels.

Zayas%25252520Headshot%25252520in%25252520Color_edited_edited_edited_edited.jpg